LEVOSIMENDAN FOR TREATING PULMONARY HYPERTENSION WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION (PH-HFpEF)
20191216
CN-110885315-A
Preparation method of important intermediate of levosimendan
20191213
US-2020330463-A1
Pharmaceutical Compositions for Subcutaneous Administration of Levosimendan
20180821
CN-110831599-A
Compounds, compositions and methods for cancer treatment
20170203
EP-3576742-A1
Compounds, compositions and methods for cancer treatment
20170203
PMID
Publication Date
Title
Journal
22980396
20121101
[Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease]
Revista espanola de anestesiologia y reanimacion
23034494
20121001
Beneficial effects of levosimendan in infants with sepsis-associated cardiac dysfunction: report of 2 cases
Pediatric emergency care
22249394
20120901
Levosimendan infusion improves cardiac output but not blood pressure in a rodent model of severe metoprolol toxicity
Human & experimental toxicology
22622649
20120901
Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
21784540
20120823
Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan
If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?